206438-31-5Relevant articles and documents
Optimization of dipeptidic inhibitors of cathepsin L for improved Toxoplasma gondii selectivity and CNS permeability
Zwicker, Jeffery D.,Diaz, Nicolas A.,Guerra, Alfredo J.,Kirchhoff, Paul D.,Wen, Bo,Sun, Duxin,Carruthers, Vern B.,Larsen, Scott D.
supporting information, p. 1972 - 1980 (2018/04/14)
The neurotropic protozoan Toxoplasma gondii is the second leading cause of death due to foodborne illness in the US, and has been designated as one of five neglected parasitic infections by the Center for Disease Control and Prevention. Currently, no trea
NEW IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS
-
Page/Page column 28, (2008/06/13)
Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
Statine derivatives for the treatment of Alzheimer's disease III
-
Page/Page column 33, (2010/11/08)
The invention relates to a compound of the formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and R8 are defined as in the specification and claims and to its use for treating or preventing Alzheimer's disease and other similar diseases.